Course: Development of High-Dose Biologics Dosage Forms

222 views

Published on

Course: Development of High Dose Biologics Dosage Forms will be held on May 6, 2014 in Boston, MA - part of the Biologics Formulation & Delivery Summit.

Published in: Science
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
222
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Course: Development of High-Dose Biologics Dosage Forms

  1. 1. Dinner Short Course: Organized by Cambridge Healthtech Institute Development of High-Dose Biologics Dosage Forms Tuesday, May 6, 2014 | 6:00-9:00 pm Seaport World Trade Center, Boston, MA (Dinner will be served) Topics to be covered: Why are high concentration dosage forms increasingly becoming important? What are the challenges of high doses? What factors define them? Viscosity limitations in production and delivery Current state of the art with devices for high-volume injections • Current understanding of what causes high viscosity in mAbs • Studies probing underlying molecular mechanisms • Engineering high viscosity causing molecules • High-throughput (HT) methods for measuring viscosity: Ensuring accuracy and precision • HT screening tools for predicting viscosity • Excipients for reducing viscosity • Aggregation in high-concentration formulations • Temperature dependence of viscosity Fill/finish challenges Alternate methods of producing high concentration MAb solutions Instructors: Christopher M. Olsen, Ph.D., Senior Scientist, CMC Analytical Chemistry, Alcon Laboratories, Inc., a Division of Novartis Nicholas J. Darton, Ph.D., Platform Manager, Arecor Ltd. How to Register: Web: http://chidb.com/register/2014/pfm/reg.asp Call: 781-972-5400 Email: reg@healthtech.com This course is part of the Biologics Formulation & Delivery Summit. www.healthtech.com/biologics-delivery

×